- Home
- FFWM vs AURA Comparison
FFWM vs AURA Comparison
Compare FFWM & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- AURA
- Stock Information
- Founded
- FFWM 1990
- AURA 2007
- Country
- FFWM United States
- AURA United States
- Employees
- FFWM 551
- AURA N/A
- Industry
- FFWM Major Banks
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- FFWM Finance
- AURA Health Care
- Exchange
- FFWM Nasdaq
- AURA Nasdaq
- Market Cap
- FFWM 441.6M
- AURA 396.8M
- IPO Year
- FFWM 2014
- AURA 2021
- Fundamental
- Price
- FFWM $5.46
- AURA $6.02
- Analyst Decision
- FFWM Buy
- AURA Strong Buy
- Analyst Count
- FFWM 2
- AURA 7
- Target Price
- FFWM $6.25
- AURA $22.29
- AVG Volume (30 Days)
- FFWM 665.2K
- AURA 253.2K
- Earning Date
- FFWM 10-30-2025
- AURA 11-11-2025
- Dividend Yield
- FFWM N/A
- AURA N/A
- EPS Growth
- FFWM N/A
- AURA N/A
- EPS
- FFWM N/A
- AURA N/A
- Revenue
- FFWM $104,325,000.00
- AURA N/A
- Revenue This Year
- FFWM $164.55
- AURA N/A
- Revenue Next Year
- FFWM $9.56
- AURA N/A
- P/E Ratio
- FFWM N/A
- AURA N/A
- Revenue Growth
- FFWM N/A
- AURA N/A
- 52 Week Low
- FFWM $4.42
- AURA $4.35
- 52 Week High
- FFWM $8.52
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- FFWM 43.85
- AURA 47.71
- Support Level
- FFWM $5.17
- AURA $5.55
- Resistance Level
- FFWM $5.92
- AURA $6.62
- Average True Range (ATR)
- FFWM 0.21
- AURA 0.32
- MACD
- FFWM -0.05
- AURA 0.01
- Stochastic Oscillator
- FFWM 34.97
- AURA 43.82
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.